In the May 6 article “Aetna bid to derail whistleblower case against CVS denied,” The Columbus Dispatch quoted AAI President Diana Moss:
Diana Moss, president of the American Antitrust Institute, said she couldn’t comment on the specifics of Behnke’s whistleblower case, but she said in general that the interests of CVS and Aetna can be discerned.
“I think it is safe to say that the companies at this juncture have incentives to downplay any legal issues that arise between them, given the pendancy of their vertical merger,” Moss said in an email.
See more of AAI’s analysis of the CVS-Aetna merger.
